GO
Loading...

Bristol-Myers to Pay $1 Million Criminal Fine in Plavix Case

Bristol-Myers Squibb has agreed to pay a $1 million criminal fine for lying to the federal government about a patent deal involving its Plavix blood thinner, the Justice Department said.

The fine resolves a two-count criminal charge filed by the department in federal court, which alleges that Bristol-Myers illegally concealed a patent settlement deal it had reached with Canadian drug maker Apotex, the department said.

The patent settlement at issue would have delayed generic competition to Plavix, but it collapsed.

Bristol-Myers announced on May 10 that it had agreed to plead guilty in connection with the case and said the charges carried a maximum fine of $1 million.

In a statement Wednesday, Bristol-Myers said the court documents filed by the government on Wednesday was "the next procedural step in completing our previously announced agreement to resolve the federal antitrust investigation."

Regarding allegations that Bristol-Myers had reached illegal side agreements with Apotex to block its generic version, company spokesman Tony Plohoros said only that, "Our position on this has been mischaracterized."

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

  • American universities produce the majority of the world's billionaires, according to this year's Wealth-X and UBS Billionaire Census report.

  • Tips for takeout?

    Our story this week on one man's food bonanza gave rise to the pragmatic if not really important question: Should you tip on take out orders?

  • Pablo Sandoval of the San Francisco Giants

    Batter up: Tucci and other upstart bat makers are challenging the Louisville Slugger in this year's World Series.

U.S. Video